← Back to dashboard
Intuitive Surgical
Intuitive is the dominant public surgical robotics franchise and belongs in any serious robotics basket.
Metric timing
This page mixes live market data, trailing fundamentals, and latest reported statement data.
Live / market snapshot
Price, 1D change, market cap, and enterprise value are current market-based figures.
TTM / forward
Most valuation and margin cards are trailing twelve months, while forward P/E uses forward consensus.
Latest quarter / dividend cadence
Balance-sheet ratios use the latest reported quarter. Dividend cadence is inferred from recent payout history.
latest annual revenue
latest quarterly revenue
latest annual profit
latest quarterly profit
annualized per share
latest ex-dividend cash amount
Latest headlines
Recent company headlines. Each link opens the original article in a new tab.
Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock
Intuitive Surgical (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Intuitive Surgical (ISRG): The Best Healthcare AI Stock to Buy According to AnalystsIntuitive Surgical, Inc. (NASDAQ:ISRG) is one of the 8 Best Healthcare AI Stocks to Buy According to Analysts. On April 23, 2026, Barclays lowered its price target on Intuitive Surgical, Inc. (NASDAQ:ISRG) to $651 from $712 while maintaining an Overweight rating following the company’s Q1 results. The firm said the quarter delivered a “strong fundamental […]
UFP Tech (UFPT) Q2 2025 Earnings TranscriptR. Jeffrey Bailly: Thank you, Ron, and thank you to everyone joining the call. UFP had a strong second quarter. Revenue from our two largest customers, Intuitive Surgical and Stryker, grew 10% and 567%, respectively.
Assessing Intuitive Surgical (ISRG) Valuation As Recent Share Price Weakness Meets Strong Long Term ReturnsWhy Intuitive Surgical stock is drawing attention now Intuitive Surgical (ISRG) is back in focus after a choppy stretch for the stock, prompting investors to reassess how its current share price lines up with recent returns and the scale of its surgical robotics business. See our latest analysis for Intuitive Surgical. At a share price of US$457.78, Intuitive Surgical has seen a 1-day share price return close to flat, a 7-day share price return of a 2.8% decline, and a year-to-date share...
Is Intuitive Surgical, Inc. (ISRG) A Good Stock To Buy Now?Is ISRG a good stock to buy? We came across a bullish thesis on Intuitive Surgical, Inc. on Rijnberk InvestInsights’s Substack by Daan | InvestInsights. In this article, we will summarize the bulls’ thesis on ISRG. Intuitive Surgical, Inc.’s share was trading at $451.29 as of April 21st. ISRG’s trailing and forward P/E were 59.16 and 46.51 […]
Jim Cramer Believes Competitors Might Hurt Intuitive SurgicalIntuitive Surgical, Inc. (NASDAQ:ISRG) was among the stocks Jim Cramer highlighted, as he discussed the massive AI infrastructure buildout. A caller asked for Cramer’s thoughts on the company, and he said: Here’s the thing: Both J&J and Medtronic claim they’ve got competitors. And I am worried that one of those two is going to hit […]
Why it could benefit going forward
- Intuitive is the dominant public surgical robotics franchise and belongs in any serious robotics basket.
- Its installed base, procedure growth, and recurring instruments model create a stronger moat than most robotics names.
- This adds a high-quality medical robotics angle that is less tied to data-center spending or industrial cycles.
Moat / edge
- Large installed base and deep surgeon training ecosystem.
- Recurring revenue from instruments, accessories, and service.
- Years of lead time and brand strength in robotic-assisted surgery.
What to watch
- Procedure growth and system placements.
- Adoption of newer da Vinci platforms and adjacent products.
- Gross-margin resilience as the business scales.
Key risks
- Premium valuation can leave less room for execution misses.
- Hospital capital-spending cycles still matter.
Business snapshot
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.